Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses

Eur J Med Chem. 2019 Sep 15:178:606-622. doi: 10.1016/j.ejmech.2019.06.008. Epub 2019 Jun 11.

Abstract

The hydrophobic pocket within viral capsid protein 1 is a target to combat the rhino- and enteroviruses (RV and EV) using small molecules. The highly conserved amino acids lining this pocket enable the development of antivirals with broad-spectrum of activity against numerous RVs and EVs. Inhibitor binding blocks: the attachment of the virion to the host cell membrane, viral uncoating, and/or production of infectious virus particles. Syntheses and biological studies of the most well-known antipicornaviral capsid binders have been reviewed and we propose next steps in this research.

Keywords: Antivirals; Common cold; Drug design/discovery; Enterovirus; Pleconaril; Rhinovirus.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology*
  • Binding Sites / drug effects
  • Capsid / metabolism*
  • Dose-Response Relationship, Drug
  • Enterovirus / chemistry
  • Enterovirus / drug effects*
  • Humans
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Structure-Activity Relationship

Substances

  • Antiviral Agents